Clozaril
Product Images NDC 64725-1260

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Clozaril (NDC 64725-1260). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Tya Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (64725 1260)

CLOZARIL is a medication formulated as tablets containing 25mg of the active ingredient Clozapine, manufactured by Novartis. The medication is packaged in blister packs containing 30 tablets per container, and the lot number is printed on the package. The packaging company is TY.A Pharmaceuticals, located in Tallahassee, Florida, with a contact phone number available. The recommended dose and additional information can be found in the package insert.*

FDA Label Image

Clozapine Structural Formula (Clozaril 02)

FDA Label Image

Figure 2: Kaplan Meier Estimates Of Cumulative Probability Of A Significant Suicide Attempt Or Hospitalization To Prevent Suicide. (Clozaril 03)

FDA Label Image

Figure 1: Resuming Monitoring Frequency After Interruption In Therapy (Clozaril 04)

This text is a medical record about treatment duration and monitoring of blood events. It includes tables that show the different treatment duration, abnormal and no abnormal blood events, WBC counts, ANC, rechallengeable, and instructions for weekly and monthly monitoring. The transitions to reduce the frequency of monitoring are only allowed if the WBC counts are normal.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.